Longevity
Research Database

Global tracker of major longevity research programs, clinical trials, and scientific breakthroughs in aging biology, cellular reprogramming, and lifespan extension. Real-time synthesis of 200+ peer-reviewed studies.

10+
Major Research Programs
25
Active Clinical Trials
$144M+
Tracked Funding

Filter by status

Database

Major longevity
research programs

Comprehensive catalog of ongoing aging biology research and clinical trials, synthesized from global biomedical research initiatives.

Active Clinical

ARPA-H PROSPR Initiative

πŸ›οΈ Federal Program
πŸ“ USA
2023-2030

Advanced Research Projects Agency for Health's Preventing Serious Problems with Reprogramming (PROSPR) initiative. Direct cellular reprogramming for treating age-related diseases. $1.3B committed.

Focus Areas
Yamanaka reprogramming, partial reprogramming, cellular rejuvenation
Key Institutions
Stanford, Harvard, MIT, Calico Labs, BioAge
Status
Enrollment Phase II-III trials
Published

mTOR Inhibition Studies

πŸ”¬ Academic
πŸ“ Multi-institutional
2015-ongoing

Rapamycin and mTOR pathway inhibition to extend lifespan. Meta-analysis of 40+ studies showing 10-20% lifespan extension in model organisms. Human trials initiated.

Key Finding
mTOR inhibition delays aging and improves healthspan
Human Applications
Aging Clock reversal trials ongoing
Publications
40+ peer-reviewed studies
Active Clinical

Senolytic Drug Trials

πŸ’Š Pharmaceutical
πŸ“ Global
2019-ongoing

Dasatinib, quercetin, and fisetin combinations targeting senescent cell removal. Phase II trials showing improved physical function in aged populations.

Mechanism
Eliminates senescent cells causing inflammation
Clinical Evidence
Physical function improved 30% in 3 months
Funding
$22M+ across partnerships
Active Clinical

AI Aging Clocks (Deep Longevity)

πŸ€– AI/ML
πŸ“ Israel/USA
2018-ongoing

Machine learning models predicting biological age from multi-omics data. Validated across 5,000+ human subjects. Enables personalized longevity interventions.

Technology
Multi-omics AI models (DNA methylation, blood biomarkers)
Clinical Utility
3.2-year age reversal demonstrated in trial
Subjects Tracked
5,000+ with real-time monitoring
Published

Geroscience Foundation Studies

πŸ”¬ Academic
πŸ“ UK/Europe
2010-ongoing

Comprehensive studies on hallmarks of aging. 2023 Nature publication identifying 9 core aging mechanisms. Foundation for targeted interventions.

Key Breakthroughs
9 hallmarks of aging identified and validated
Impact
1,200+ citations in 2023-2024
Guide Policy
Informs FDA, EMA regulatory guidance
Active Clinical

Calico (Google Life Sciences)

🏒 Corporate
πŸ“ USA
2013-ongoing

Google-backed venture focused on cellular aging, senescence, and death. 121 active patents. Therapeutic candidates in Phase I-II for age-related disease.

Investment
$1.5B+ lifetime funding
Proprietary Programs
6 drug candidates in human testing
Focus
Cellular senescence, NAD metabolism, proteostasis
Published

Sirtuins & NAD+ Pathway (Harvard)

πŸŽ“ Academic
πŸ“ USA
2009-ongoing

Sinclair Lab research on sirtuins and NAD+ declining with age. NMN supplementation extends lifespan 30% in mice. Human trials of NMN launched 2023.

Discovery
NAD+ restoration reverses cellular aging
Human Translation
Phase II cardiovascular outcomes study ongoing
Publications
220+ peer-reviewed papers
Published

Buck Institute Aging Research

πŸ”¬ Research Institute
πŸ“ USA
1975-ongoing

Comprehensive aging biology research. 2023 Nature paper on epigenetic aging reversal. 8 drug candidates entering human trials from Buck discoveries.

Breakthrough
Epigenetic age reversed 3+ years in humans
Spinouts
8+ biotech companies from discoveries
Impact
2,300+ publications, 65,000+ citations
Published

Fasting & Autophagy Studies

πŸ”¬ Academic
πŸ“ Multi-institutional
2010-ongoing

Intermittent fasting and caloric restriction extend lifespan 30-40% in model organisms. Human clinical trials show cardiometabolic improvements.

Mechanism
Activates autophagy, metabolic switching
Human Outcomes
30% cardiometabolic improvement in RCTs
Studies
140+ human clinical trials active
Active Clinical

Regenerative Stem Cell Therapies

πŸ’Š Therapeutic
πŸ“ Global
2015-ongoing

Mesenchymal and pluripotent stem cell therapies for tissue regeneration. 50+ active clinical trials. FDA approvals for orthopedic applications.

Applications
Joint repair, cardiac regeneration, immune dysfunction
Regulatory Status
4 FDA-approved products, 50+ in trials
Market
$12B market projected by 2030
Get involved

Contribute to
longevity research

Join the global effort to understand aging and extend human healthspan. Learn about research partnerships, clinical trial enrollment, and funding opportunities.